Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
Identifieur interne : 003546 ( Main/Exploration ); précédent : 003545; suivant : 003547Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
Auteurs : Stefan Zeuzem ; Ira M. Jacobson ; Tolga Baykal ; Rui T. Marinho ; Fred Poordad ; Marc Bourlière ; Mark S. Sulkowski ; Heiner Wedemeyer ; Edward Tam ; Paul Desmond ; Donald M. Jensen ; Adrian M. Di Bisceglie ; Peter Varunok ; Tarek Hassanein ; Junyuan Xiong ; Tami Pilot-Matias ; Barbara Dasilva-Tillmann ; Lois Larsen ; Thomas Podsadecki ; Barry BernsteinSource :
- The New England journal of medicine [ 1533-4406 ] ; 2014.
Descripteurs français
- KwdFr :
- ARN viral (isolement et purification), Adolescent, Adulte, Adulte d'âge moyen, Anilides (effets indésirables), Anilides (usage thérapeutique), Antiviraux (effets indésirables), Antiviraux (usage thérapeutique), Association médicamenteuse, Carbamates (effets indésirables), Carbamates (usage thérapeutique), Charge virale, Composés macrocycliques (effets indésirables), Composés macrocycliques (usage thérapeutique), Femelle, Hepacivirus (génétique), Hepacivirus (isolement et purification), Humains, Hépatite C chronique (traitement médicamenteux), Hépatite C chronique (virologie), Jeune adulte, Mâle, Méthode en double aveugle, Reprise du traitement, Ribavirine (effets indésirables), Ribavirine (usage thérapeutique), Ritonavir (effets indésirables), Ritonavir (usage thérapeutique), Sujet âgé, Sulfonamides (effets indésirables), Sulfonamides (usage thérapeutique), Uracile (analogues et dérivés), Uracile (effets indésirables), Uracile (usage thérapeutique).
- MESH :
- analogues et dérivés : Uracile.
- effets indésirables : Anilides, Antiviraux, Carbamates, Composés macrocycliques, Ribavirine, Ritonavir, Sulfonamides, Uracile.
- génétique : Hepacivirus.
- isolement et purification : ARN viral, Hepacivirus.
- traitement médicamenteux : Hépatite C chronique.
- usage thérapeutique : Anilides, Antiviraux, Carbamates, Composés macrocycliques, Ribavirine, Ritonavir, Sulfonamides, Uracile.
- virologie : Hépatite C chronique.
- Adolescent, Adulte, Adulte d'âge moyen, Association médicamenteuse, Charge virale, Femelle, Humains, Jeune adulte, Mâle, Méthode en double aveugle, Reprise du traitement, Sujet âgé.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Anilides (adverse effects), Anilides (therapeutic use), Antiviral Agents (adverse effects), Antiviral Agents (therapeutic use), Carbamates (adverse effects), Carbamates (therapeutic use), Double-Blind Method, Drug Combinations, Female, Hepacivirus (genetics), Hepacivirus (isolation & purification), Hepatitis C, Chronic (drug therapy), Hepatitis C, Chronic (virology), Humans, Macrocyclic Compounds (adverse effects), Macrocyclic Compounds (therapeutic use), Male, Middle Aged, RNA, Viral (isolation & purification), Retreatment, Ribavirin (adverse effects), Ribavirin (therapeutic use), Ritonavir (adverse effects), Ritonavir (therapeutic use), Sulfonamides (adverse effects), Sulfonamides (therapeutic use), Uracil (adverse effects), Uracil (analogs & derivatives), Uracil (therapeutic use), Viral Load, Young Adult.
- MESH :
- chemical , adverse effects : Anilides, Antiviral Agents, Carbamates, Macrocyclic Compounds, Ribavirin, Ritonavir, Sulfonamides, Uracil.
- chemical , analogs & derivatives : Uracil.
- chemical , isolation & purification : RNA, Viral.
- chemical , therapeutic use : Anilides, Antiviral Agents, Carbamates, Macrocyclic Compounds, Ribavirin, Ritonavir, Sulfonamides, Uracil.
- drug therapy : Hepatitis C, Chronic.
- genetics : Hepacivirus.
- isolation & purification : Hepacivirus.
- virology : Hepatitis C, Chronic.
- Adolescent, Adult, Aged, Double-Blind Method, Drug Combinations, Female, Humans, Male, Middle Aged, Retreatment, Viral Load, Young Adult.
Abstract
In this phase 3 trial we evaluated the efficacy and safety of the interferon-free combination of ABT-450 with ritonavir (ABT-450/r), ombitasvir (also known as ABT-267), dasabuvir (also known as ABT-333), and ribavirin for the retreatment of HCV in patients who were previously treated with peginterferon-ribavirin.
DOI: 10.1056/NEJMoa1401561
PubMed: 24720679
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003843
- to stream PubMed, to step Curation: 003729
- to stream PubMed, to step Checkpoint: 003729
- to stream Ncbi, to step Merge: 001953
- to stream Ncbi, to step Curation: 001953
- to stream Ncbi, to step Checkpoint: 001953
- to stream Main, to step Merge: 003562
- to stream Main, to step Curation: 003546
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.</title><author><name sortKey="Zeuzem, Stefan" sort="Zeuzem, Stefan" uniqKey="Zeuzem S" first="Stefan" last="Zeuzem">Stefan Zeuzem</name><affiliation><nlm:affiliation>From Johann Wolfgang Goethe University, Frankfurt am Main (S.Z.), and Medizinische Hochschule Hannover, Hannover (H.W.) - both in Germany; Weill Cornell Medical College, New York (I.M.J.), and Premier Medical Group of the Hudson Valley, Poughkeepsie (P.V.) - both in New York; AbbVie, North Chicago (T.B., J.X., T.P.-M., B.D.-T., L.L., T.P., B.B.), and Center for Liver Diseases, University of Chicago Medical Center, Chicago (D.M.J.) - both in Illinois; Centro Hospitalar de Lisboa Norte and Medical School of Lisbon, Lisbon, Portugal (R.T.M.); Texas Liver Institute, University of Texas Health Science Center, San Antonio (F.P.); Hôpital Saint Joseph, Marseille, France (M.B.); Johns Hopkins University, Baltimore (M.S.S.); Liver and Intestinal Research Centre, Vancouver, BC, Canada (E.T.); St. Vincent's Hospital (Melbourne), Fitzroy, Australia (P.D.); Saint Louis University, St. Louis (A.M.D.); and Southern California Liver Centers and Southern California Research Center, Coronado (T.H.).</nlm:affiliation><wicri:noCountry code="subField">Coronado (T.H.).</wicri:noCountry></affiliation></author><author><name sortKey="Jacobson, Ira M" sort="Jacobson, Ira M" uniqKey="Jacobson I" first="Ira M" last="Jacobson">Ira M. Jacobson</name></author><author><name sortKey="Baykal, Tolga" sort="Baykal, Tolga" uniqKey="Baykal T" first="Tolga" last="Baykal">Tolga Baykal</name></author><author><name sortKey="Marinho, Rui T" sort="Marinho, Rui T" uniqKey="Marinho R" first="Rui T" last="Marinho">Rui T. Marinho</name></author><author><name sortKey="Poordad, Fred" sort="Poordad, Fred" uniqKey="Poordad F" first="Fred" last="Poordad">Fred Poordad</name></author><author><name sortKey="Bourliere, Marc" sort="Bourliere, Marc" uniqKey="Bourliere M" first="Marc" last="Bourlière">Marc Bourlière</name></author><author><name sortKey="Sulkowski, Mark S" sort="Sulkowski, Mark S" uniqKey="Sulkowski M" first="Mark S" last="Sulkowski">Mark S. Sulkowski</name></author><author><name sortKey="Wedemeyer, Heiner" sort="Wedemeyer, Heiner" uniqKey="Wedemeyer H" first="Heiner" last="Wedemeyer">Heiner Wedemeyer</name></author><author><name sortKey="Tam, Edward" sort="Tam, Edward" uniqKey="Tam E" first="Edward" last="Tam">Edward Tam</name></author><author><name sortKey="Desmond, Paul" sort="Desmond, Paul" uniqKey="Desmond P" first="Paul" last="Desmond">Paul Desmond</name></author><author><name sortKey="Jensen, Donald M" sort="Jensen, Donald M" uniqKey="Jensen D" first="Donald M" last="Jensen">Donald M. Jensen</name></author><author><name sortKey="Di Bisceglie, Adrian M" sort="Di Bisceglie, Adrian M" uniqKey="Di Bisceglie A" first="Adrian M" last="Di Bisceglie">Adrian M. Di Bisceglie</name></author><author><name sortKey="Varunok, Peter" sort="Varunok, Peter" uniqKey="Varunok P" first="Peter" last="Varunok">Peter Varunok</name></author><author><name sortKey="Hassanein, Tarek" sort="Hassanein, Tarek" uniqKey="Hassanein T" first="Tarek" last="Hassanein">Tarek Hassanein</name></author><author><name sortKey="Xiong, Junyuan" sort="Xiong, Junyuan" uniqKey="Xiong J" first="Junyuan" last="Xiong">Junyuan Xiong</name></author><author><name sortKey="Pilot Matias, Tami" sort="Pilot Matias, Tami" uniqKey="Pilot Matias T" first="Tami" last="Pilot-Matias">Tami Pilot-Matias</name></author><author><name sortKey="Dasilva Tillmann, Barbara" sort="Dasilva Tillmann, Barbara" uniqKey="Dasilva Tillmann B" first="Barbara" last="Dasilva-Tillmann">Barbara Dasilva-Tillmann</name></author><author><name sortKey="Larsen, Lois" sort="Larsen, Lois" uniqKey="Larsen L" first="Lois" last="Larsen">Lois Larsen</name></author><author><name sortKey="Podsadecki, Thomas" sort="Podsadecki, Thomas" uniqKey="Podsadecki T" first="Thomas" last="Podsadecki">Thomas Podsadecki</name></author><author><name sortKey="Bernstein, Barry" sort="Bernstein, Barry" uniqKey="Bernstein B" first="Barry" last="Bernstein">Barry Bernstein</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24720679</idno><idno type="pmid">24720679</idno><idno type="doi">10.1056/NEJMoa1401561</idno><idno type="wicri:Area/PubMed/Corpus">003843</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003843</idno><idno type="wicri:Area/PubMed/Curation">003729</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003729</idno><idno type="wicri:Area/PubMed/Checkpoint">003729</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003729</idno><idno type="wicri:Area/Ncbi/Merge">001953</idno><idno type="wicri:Area/Ncbi/Curation">001953</idno><idno type="wicri:Area/Ncbi/Checkpoint">001953</idno><idno type="wicri:Area/Main/Merge">003562</idno><idno type="wicri:Area/Main/Curation">003546</idno><idno type="wicri:Area/Main/Exploration">003546</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.</title><author><name sortKey="Zeuzem, Stefan" sort="Zeuzem, Stefan" uniqKey="Zeuzem S" first="Stefan" last="Zeuzem">Stefan Zeuzem</name><affiliation><nlm:affiliation>From Johann Wolfgang Goethe University, Frankfurt am Main (S.Z.), and Medizinische Hochschule Hannover, Hannover (H.W.) - both in Germany; Weill Cornell Medical College, New York (I.M.J.), and Premier Medical Group of the Hudson Valley, Poughkeepsie (P.V.) - both in New York; AbbVie, North Chicago (T.B., J.X., T.P.-M., B.D.-T., L.L., T.P., B.B.), and Center for Liver Diseases, University of Chicago Medical Center, Chicago (D.M.J.) - both in Illinois; Centro Hospitalar de Lisboa Norte and Medical School of Lisbon, Lisbon, Portugal (R.T.M.); Texas Liver Institute, University of Texas Health Science Center, San Antonio (F.P.); Hôpital Saint Joseph, Marseille, France (M.B.); Johns Hopkins University, Baltimore (M.S.S.); Liver and Intestinal Research Centre, Vancouver, BC, Canada (E.T.); St. Vincent's Hospital (Melbourne), Fitzroy, Australia (P.D.); Saint Louis University, St. Louis (A.M.D.); and Southern California Liver Centers and Southern California Research Center, Coronado (T.H.).</nlm:affiliation><wicri:noCountry code="subField">Coronado (T.H.).</wicri:noCountry></affiliation></author><author><name sortKey="Jacobson, Ira M" sort="Jacobson, Ira M" uniqKey="Jacobson I" first="Ira M" last="Jacobson">Ira M. Jacobson</name></author><author><name sortKey="Baykal, Tolga" sort="Baykal, Tolga" uniqKey="Baykal T" first="Tolga" last="Baykal">Tolga Baykal</name></author><author><name sortKey="Marinho, Rui T" sort="Marinho, Rui T" uniqKey="Marinho R" first="Rui T" last="Marinho">Rui T. Marinho</name></author><author><name sortKey="Poordad, Fred" sort="Poordad, Fred" uniqKey="Poordad F" first="Fred" last="Poordad">Fred Poordad</name></author><author><name sortKey="Bourliere, Marc" sort="Bourliere, Marc" uniqKey="Bourliere M" first="Marc" last="Bourlière">Marc Bourlière</name></author><author><name sortKey="Sulkowski, Mark S" sort="Sulkowski, Mark S" uniqKey="Sulkowski M" first="Mark S" last="Sulkowski">Mark S. Sulkowski</name></author><author><name sortKey="Wedemeyer, Heiner" sort="Wedemeyer, Heiner" uniqKey="Wedemeyer H" first="Heiner" last="Wedemeyer">Heiner Wedemeyer</name></author><author><name sortKey="Tam, Edward" sort="Tam, Edward" uniqKey="Tam E" first="Edward" last="Tam">Edward Tam</name></author><author><name sortKey="Desmond, Paul" sort="Desmond, Paul" uniqKey="Desmond P" first="Paul" last="Desmond">Paul Desmond</name></author><author><name sortKey="Jensen, Donald M" sort="Jensen, Donald M" uniqKey="Jensen D" first="Donald M" last="Jensen">Donald M. Jensen</name></author><author><name sortKey="Di Bisceglie, Adrian M" sort="Di Bisceglie, Adrian M" uniqKey="Di Bisceglie A" first="Adrian M" last="Di Bisceglie">Adrian M. Di Bisceglie</name></author><author><name sortKey="Varunok, Peter" sort="Varunok, Peter" uniqKey="Varunok P" first="Peter" last="Varunok">Peter Varunok</name></author><author><name sortKey="Hassanein, Tarek" sort="Hassanein, Tarek" uniqKey="Hassanein T" first="Tarek" last="Hassanein">Tarek Hassanein</name></author><author><name sortKey="Xiong, Junyuan" sort="Xiong, Junyuan" uniqKey="Xiong J" first="Junyuan" last="Xiong">Junyuan Xiong</name></author><author><name sortKey="Pilot Matias, Tami" sort="Pilot Matias, Tami" uniqKey="Pilot Matias T" first="Tami" last="Pilot-Matias">Tami Pilot-Matias</name></author><author><name sortKey="Dasilva Tillmann, Barbara" sort="Dasilva Tillmann, Barbara" uniqKey="Dasilva Tillmann B" first="Barbara" last="Dasilva-Tillmann">Barbara Dasilva-Tillmann</name></author><author><name sortKey="Larsen, Lois" sort="Larsen, Lois" uniqKey="Larsen L" first="Lois" last="Larsen">Lois Larsen</name></author><author><name sortKey="Podsadecki, Thomas" sort="Podsadecki, Thomas" uniqKey="Podsadecki T" first="Thomas" last="Podsadecki">Thomas Podsadecki</name></author><author><name sortKey="Bernstein, Barry" sort="Bernstein, Barry" uniqKey="Bernstein B" first="Barry" last="Bernstein">Barry Bernstein</name></author></analytic><series><title level="j">The New England journal of medicine</title><idno type="eISSN">1533-4406</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Anilides (adverse effects)</term><term>Anilides (therapeutic use)</term><term>Antiviral Agents (adverse effects)</term><term>Antiviral Agents (therapeutic use)</term><term>Carbamates (adverse effects)</term><term>Carbamates (therapeutic use)</term><term>Double-Blind Method</term><term>Drug Combinations</term><term>Female</term><term>Hepacivirus (genetics)</term><term>Hepacivirus (isolation & purification)</term><term>Hepatitis C, Chronic (drug therapy)</term><term>Hepatitis C, Chronic (virology)</term><term>Humans</term><term>Macrocyclic Compounds (adverse effects)</term><term>Macrocyclic Compounds (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>RNA, Viral (isolation & purification)</term><term>Retreatment</term><term>Ribavirin (adverse effects)</term><term>Ribavirin (therapeutic use)</term><term>Ritonavir (adverse effects)</term><term>Ritonavir (therapeutic use)</term><term>Sulfonamides (adverse effects)</term><term>Sulfonamides (therapeutic use)</term><term>Uracil (adverse effects)</term><term>Uracil (analogs & derivatives)</term><term>Uracil (therapeutic use)</term><term>Viral Load</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral (isolement et purification)</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anilides (effets indésirables)</term><term>Anilides (usage thérapeutique)</term><term>Antiviraux (effets indésirables)</term><term>Antiviraux (usage thérapeutique)</term><term>Association médicamenteuse</term><term>Carbamates (effets indésirables)</term><term>Carbamates (usage thérapeutique)</term><term>Charge virale</term><term>Composés macrocycliques (effets indésirables)</term><term>Composés macrocycliques (usage thérapeutique)</term><term>Femelle</term><term>Hepacivirus (génétique)</term><term>Hepacivirus (isolement et purification)</term><term>Humains</term><term>Hépatite C chronique (traitement médicamenteux)</term><term>Hépatite C chronique (virologie)</term><term>Jeune adulte</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Reprise du traitement</term><term>Ribavirine (effets indésirables)</term><term>Ribavirine (usage thérapeutique)</term><term>Ritonavir (effets indésirables)</term><term>Ritonavir (usage thérapeutique)</term><term>Sujet âgé</term><term>Sulfonamides (effets indésirables)</term><term>Sulfonamides (usage thérapeutique)</term><term>Uracile (analogues et dérivés)</term><term>Uracile (effets indésirables)</term><term>Uracile (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anilides</term><term>Antiviral Agents</term><term>Carbamates</term><term>Macrocyclic Compounds</term><term>Ribavirin</term><term>Ritonavir</term><term>Sulfonamides</term><term>Uracil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Uracil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anilides</term><term>Antiviral Agents</term><term>Carbamates</term><term>Macrocyclic Compounds</term><term>Ribavirin</term><term>Ritonavir</term><term>Sulfonamides</term><term>Uracil</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Uracile</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anilides</term><term>Antiviraux</term><term>Carbamates</term><term>Composés macrocycliques</term><term>Ribavirine</term><term>Ritonavir</term><term>Sulfonamides</term><term>Uracile</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Hepacivirus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Hepacivirus</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Hepacivirus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>ARN viral</term><term>Hepacivirus</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anilides</term><term>Antiviraux</term><term>Carbamates</term><term>Composés macrocycliques</term><term>Ribavirine</term><term>Ritonavir</term><term>Sulfonamides</term><term>Uracile</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Hépatite C chronique</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Hepatitis C, Chronic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Double-Blind Method</term><term>Drug Combinations</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retreatment</term><term>Viral Load</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association médicamenteuse</term><term>Charge virale</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Reprise du traitement</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In this phase 3 trial we evaluated the efficacy and safety of the interferon-free combination of ABT-450 with ritonavir (ABT-450/r), ombitasvir (also known as ABT-267), dasabuvir (also known as ABT-333), and ribavirin for the retreatment of HCV in patients who were previously treated with peginterferon-ribavirin.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Baykal, Tolga" sort="Baykal, Tolga" uniqKey="Baykal T" first="Tolga" last="Baykal">Tolga Baykal</name><name sortKey="Bernstein, Barry" sort="Bernstein, Barry" uniqKey="Bernstein B" first="Barry" last="Bernstein">Barry Bernstein</name><name sortKey="Bourliere, Marc" sort="Bourliere, Marc" uniqKey="Bourliere M" first="Marc" last="Bourlière">Marc Bourlière</name><name sortKey="Dasilva Tillmann, Barbara" sort="Dasilva Tillmann, Barbara" uniqKey="Dasilva Tillmann B" first="Barbara" last="Dasilva-Tillmann">Barbara Dasilva-Tillmann</name><name sortKey="Desmond, Paul" sort="Desmond, Paul" uniqKey="Desmond P" first="Paul" last="Desmond">Paul Desmond</name><name sortKey="Di Bisceglie, Adrian M" sort="Di Bisceglie, Adrian M" uniqKey="Di Bisceglie A" first="Adrian M" last="Di Bisceglie">Adrian M. Di Bisceglie</name><name sortKey="Hassanein, Tarek" sort="Hassanein, Tarek" uniqKey="Hassanein T" first="Tarek" last="Hassanein">Tarek Hassanein</name><name sortKey="Jacobson, Ira M" sort="Jacobson, Ira M" uniqKey="Jacobson I" first="Ira M" last="Jacobson">Ira M. Jacobson</name><name sortKey="Jensen, Donald M" sort="Jensen, Donald M" uniqKey="Jensen D" first="Donald M" last="Jensen">Donald M. Jensen</name><name sortKey="Larsen, Lois" sort="Larsen, Lois" uniqKey="Larsen L" first="Lois" last="Larsen">Lois Larsen</name><name sortKey="Marinho, Rui T" sort="Marinho, Rui T" uniqKey="Marinho R" first="Rui T" last="Marinho">Rui T. Marinho</name><name sortKey="Pilot Matias, Tami" sort="Pilot Matias, Tami" uniqKey="Pilot Matias T" first="Tami" last="Pilot-Matias">Tami Pilot-Matias</name><name sortKey="Podsadecki, Thomas" sort="Podsadecki, Thomas" uniqKey="Podsadecki T" first="Thomas" last="Podsadecki">Thomas Podsadecki</name><name sortKey="Poordad, Fred" sort="Poordad, Fred" uniqKey="Poordad F" first="Fred" last="Poordad">Fred Poordad</name><name sortKey="Sulkowski, Mark S" sort="Sulkowski, Mark S" uniqKey="Sulkowski M" first="Mark S" last="Sulkowski">Mark S. Sulkowski</name><name sortKey="Tam, Edward" sort="Tam, Edward" uniqKey="Tam E" first="Edward" last="Tam">Edward Tam</name><name sortKey="Varunok, Peter" sort="Varunok, Peter" uniqKey="Varunok P" first="Peter" last="Varunok">Peter Varunok</name><name sortKey="Wedemeyer, Heiner" sort="Wedemeyer, Heiner" uniqKey="Wedemeyer H" first="Heiner" last="Wedemeyer">Heiner Wedemeyer</name><name sortKey="Xiong, Junyuan" sort="Xiong, Junyuan" uniqKey="Xiong J" first="Junyuan" last="Xiong">Junyuan Xiong</name><name sortKey="Zeuzem, Stefan" sort="Zeuzem, Stefan" uniqKey="Zeuzem S" first="Stefan" last="Zeuzem">Stefan Zeuzem</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003546 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003546 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24720679
|texte= Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24720679" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |